These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A 9-state analysis of designer stimulant, "bath salt," hospital visits reported to poison control centers. Warrick BJ, Hill M, Hekman K, Christensen R, Goetz R, Casavant MJ, Wahl M, Mowry JB, Spiller H, Anderson D, Aleguas A, Gummin D, Thomas R, Nezlek C, Smolinske S. Ann Emerg Med; 2013 Sep; 62(3):244-51. PubMed ID: 23540815 [Abstract] [Full Text] [Related]
5. Intoxications involving MDPV in Sweden during 2010-2014: Results from the STRIDA project. Beck O, Franzen L, Bäckberg M, Signell P, Helander A. Clin Toxicol (Phila); 2015 Nov; 53(9):865-73. PubMed ID: 26462932 [Abstract] [Full Text] [Related]
12. A descriptive study of an outbreak of clenbuterol-containing heroin. Hoffman RS, Kirrane BM, Marcus SM, Clenbuterol Study Investigators. Ann Emerg Med; 2008 Nov; 52(5):548-53. PubMed ID: 18501476 [Abstract] [Full Text] [Related]
15. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Hoyte CO, Jacob J, Monte AA, Al-Jumaan M, Bronstein AC, Heard KJ. Ann Emerg Med; 2012 Oct; 60(4):435-8. PubMed ID: 22575211 [Abstract] [Full Text] [Related]
19. Prevalence of new psychoactive substances: A retrospective study in hair. Rust KY, Baumgartner MR, Dally AM, Kraemer T. Drug Test Anal; 2012 Jun; 4(6):402-8. PubMed ID: 22522922 [Abstract] [Full Text] [Related]
20. Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine, and product quantification. Thornton SL, Gerona RR, Tomaszewski CA. J Med Toxicol; 2012 Sep; 8(3):310-3. PubMed ID: 22528592 [Abstract] [Full Text] [Related] Page: [Next] [New Search]